|
⚲
|
| TYRX Pharma Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001301800 |
| Sale | 2009-07-27 ($11.0 M Offered, $11.0 M Sold) |
| Fund | |
| Phone | 7322468676 |
| Address | 1 Deer Park Drive Monmouth Junction, 08852 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Scott Requadt | |
| William Dempsey | |
| Arikha Moses | |
| Charles Cahn | |
| Arthur Pappas | |
| Ray Imp | |
| Jeff Leiden | |
| William Edelman | |
| Mike Heffernan |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
SAX WSH 011, a series of SAX Capital Series Fund II, LP
✚
|
0.0 | |
|
Seven Six Capital Equity Fund, LP
✚
|
0.0 | |
|
SF 7x7, LLC
✚
|
0.0 | |
|
Shemesh Nir
✚
|
0.0 | |
|
Sing YuenWah
✚
|
0.0 | |
|
Stay Alfred Inc
✚
|
0.0 | |
|
Tisch Daniel R
✚
|
0.0 | |
|
Tron Inc.
✚
|
0.0 | |
|
Trust Jane
✚
|
0.0 | |
|
SAX SFR 032, a series of SAX Capital Series Fund IV, LP
✚
|
0.0 |